October 26, 2019
Impella RP use results in 72% patient survival and 88% native heart recovery
DETROIT–(BUSINESS WIRE)–Please replace the caption for release dated October 25, 2019 with the accompanying corrected caption.
Pharmaceuticals, Biotechnology and Life Sciences
DETROIT–(BUSINESS WIRE)–Please replace the caption for release dated October 25, 2019 with the accompanying corrected caption.
FDA post approval study shows timely identification of right heart failure and early use Abiomed’s ImMpella RP leads to higher…